Moreover, Li et al. showed that MIST1 reduced the tumorigenicity of pancreatic cancer cells and reversed EMT, partly via its effect on the SNAI1/E-cadherin signaling pathway 16. Here, SNAI1 is linked to pancreatic neoplasm.